Skip to main content
An MSF nurse aide Barnaba performs the MUAC measurement test on a child during a screening in an MSF mobile clinic at the Riverside transit site in Renk town, Upper Nile State, South Sudan.
Médecins Sans Frontières

International Activity Report 2023

An MSF nurse aide Barnaba performs the MUAC measurement test on a child during a screening in an MSF mobile clinic at the Riverside transit site in Renk town, Upper Nile State, South Sudan.
© Nasir Ghafoor/MSF
Ebola disease in DRC: find out how we're responding
Learn more

Foreword

In 2023, as the world was once again shaken by devastating natural disasters and brutal wars, Médecins Sans Frontières (MSF) worked to support people in need of medical care and basic services.

Alongside our regular activities, we launched emergency responses to powerful earthquakes in Türkiye, Syria, Morocco, and Afghanistan. We also assisted communities caught up in wars in Sudan and Palestine, and other conflicts around the world.

2023 in review

Conflict was a major driver of human suffering and vulnerability in 2023, causing many thousands of deaths worldwide and displacing record numbers of people. As in previous years, assisting communities affected by violence was a significant component of Médecins Sans Frontières (MSF) programmes.

Feature articles
The 'Time for $5' campaign calls on US diagnostics corporation Cepheid, and its parent company Danaher, to drop the price of its lifesaving GeneXpert tests to US$5 a test, so that many more people can get access to fast and accurate disease diagnosis.

The 'Time for $5' campaign is coordinated by MSF Access Campaign, together with more than 150 civil society organizations working to improve access to GeneXpert instruments and tests.

For more info: https://msfaccess.org/time-for-5
Staff from MSF’s Access Campaign protest outside the New York Stock Exchange, as part of the 'Time for $5' campaign, which calls on US companies Cepheid and Danaher to drop the price of their lifesaving GeneXpert tests. New York City, United States, September 2023.
© Marilia Gurgel
01 / 02

TB diagnosis and treatment: Breakthroughs after a decade-long journey

Consolidated efforts over the past decade have led to major breakthroughs in tackling tuberculosis (TB), including shorter, more effective treatment options, and substantial reductions in drug and test prices.

Read More

Our activities around the world in 2023

Our teams conducted medical activities in over 70 countries in 2023. Click on the map to find out more.

Facts and figures

Facts and figures

Our activities in figures
Dr Mohsin telling an elderly patient not to worry about his diagnosis, as the MSF mobile clinic will provide him with treatment and medication, Alladad village, Dadu district, Sindh

16,459,000

outpatient consultations
District Hospital Magaria, Niger. A member of the hospitals medical staff explains to mothers of patients how to use the MUAC so they can keep an eye on their children's weight and prevent them from developing malnutrition again.

3,295,700

vaccinations against measles in response to an outbreak
Gul, 40, washes his hands with the help of his son in the male inpatient department at the MSF-supported Boost hospital in Lashkar Gah, Helmand province.

1,368,700

Patients admitted

International Financial Report

Every year we publish our audited combined Financial Statements. These combined accounts are a means of transparency and accountability, providing a global overview of MSF’s work.

The International Financial report represents an aggregation of the Financial Statements of the 24 sections, 18 branch offices, numerous satellite organisations and MSF International.